Beverly Moy
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 109
- HER2/EGFR in Cancer Research 42
- Cancer Treatment and Pharmacology 39
- Global Cancer Incidence and Screening 15
-
- Advanced Breast Cancer Therapies 50
- Co-authors
- Paul E. Goss (18 shared papers)Aditya Bardia (64 shared papers)Laura M. Spring (57 shared papers)Eric P. Winer (21 shared papers)Steven J. Isakoff (47 shared papers)Ann H. Partridge (13 shared papers)Leif W. Ellisen (33 shared papers)Hope S. Rugo (18 shared papers)
- Journals
- Journal of Clinical Oncology (66 papers)Cancer Research (29 papers)The Oncologist (13 papers)Breast Cancer Research and Treatment (11 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Beverly Moy
201 papers receiving 6.2k citations
Beverly Moy's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 3.0k
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 1.3k
- Medical Terminology 7
- Radiology, Nuclear Medicine and Imaging 593
Countries citing papers authored by Beverly Moy
This map shows the geographic impact of Beverly Moy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Moy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Moy more than expected).
Fields of papers citing papers by Beverly Moy
This network shows the impact of papers produced by Beverly Moy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Moy. The network helps show where Beverly Moy may publish in the future.
Co-authors
The 25 scholars most cited alongside Beverly Moy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 215 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer Hit paper breakdown → | 2015 | 464 |
| 2 | Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future Hit paper breakdown → | 2020 | 333 |
| 3 | 2016 | 277 | |
| 4 | 2014 | 195 | |
| 5 | 2014 | 181 | |
| 6 | 2007 | 175 | |
| 7 | 2015 | 171 | |
| 8 | 2017 | 157 | |
| 9 | 2007 | 141 | |
| 10 | 2007 | 129 | |
| 11 | 2017 | 125 | |
| 12 | 2006 | 122 | |
| 13 | 2017 | 121 | |
| 14 | 2007 | 121 | |
| 15 | 2011 | 111 | |
| 16 | 2012 | 110 | |
| 17 | 2011 | 103 | |
| 18 | 2012 | 100 | |
| 19 | 2004 | 91 | |
| 20 | 2017 | 91 |
About Beverly Moy
Beverly Moy is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Economics and Econometrics and Pathology and Forensic Medicine, having authored 215 papers that have together received 6.3k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (50 papers), Breast Cancer Treatment Studies (43 papers), HER2/EGFR in Cancer Research (42 papers), Cancer Treatment and Pharmacology (39 papers), Economic and Financial Impacts of Cancer (26 papers), Cancer Genomics and Diagnostics (18 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Global Cancer Incidence and Screening (15 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (1.3k citations), Medical Terminology (7 citations) and Radiology, Nuclear Medicine and Imaging (593 citations). Beverly Moy has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Paul E. Goss, Aditya Bardia, Laura M. Spring, Eric P. Winer, Steven J. Isakoff, Ann H. Partridge, Leif W. Ellisen, Hope S. Rugo, Seth A. Wander and Nicholas C. Turner. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Oncologist, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.